You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prostate Cancer- High Risk, clinically Organ-Confined

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Boston (Flutamide (Eulexin) and Lupron or Zoladex, External Beam Radiotherapy)

Completed
  • Prostate Cancer
  • Flutamide (Eulexin) and Lupron or Zoladex
  • External Beam Radiotherapy
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 16, 2021

Adenocarcinoma, Prostate Cancer Trial in Lake Success (Stereotactic Body Radiation Therapy)

Completed
  • Adenocarcinoma
  • Prostate Cancer
  • Stereotactic Body Radiation Therapy
  • Lake Success, New York
    North Shore-LIJ Cancer Institute
Feb 7, 2022

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Prostate Cancer Trial (NLP-based Feedback)

Not yet recruiting
  • Prostate Cancer
  • NLP-based Feedback
  • (no location specified)
Jun 27, 2023

Prostate Cancer Trial in Providence (Ixabepilone, Prostatectomy)

Completed
Has Results
  • Prostate Cancer
  • Providence, Rhode Island
    Miriam Hospital
Feb 23, 2022

Prostate Cancer, Radical Prostatectomy Trial in Houston (REGN5678, Piflufolastat F18)

Not yet recruiting
  • Prostate Cancer
  • Radical Prostatectomy
  • Houston, Texas
    MD Anderson Cancer Center
Oct 10, 2023

Prostate Cancer Trial in Detroit (Educational video)

Not yet recruiting
  • Prostate Cancer
  • Educational video
  • Detroit, Michigan
    Henry Ford Cancer Pavilion
Jul 14, 2023

Androgen Deprivation Therapy, Locally Advanced Prostate Cancer Trial in Oklahoma City (Relugolix and Enzalutamide)

Not yet recruiting
  • Androgen Deprivation Therapy
  • Locally Advanced Prostate Cancer
  • Relugolix and Enzalutamide
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center at OU Health, University of Oklahoma He
Nov 8, 2023

Prostate Cancer Trial in Beijing (Darolutamide+ADT)

Not yet recruiting
  • Prostate Cancer
  • Beijing, China
    Peking University First Hospital
Sep 1, 2023

Middle-high Risk Endometrial Cancer, Sentinel Lymph Node Sampling, Prognosis Trial in Shanghai (sentinel lymph node sampling

Recruiting
  • Middle-high Risk Endometrial Cancer
  • +2 more
  • sentinel lymph node sampling (SLN)
  • pelvic lymphonodectomy (PLN)
  • Shanghai, Shanghai, China
    Obstetrics and Gynecology Hospital, Fudan University
Mar 24, 2022

Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)

Not yet recruiting
  • Prostatic Cancer
  • High Dose Brachytherapy
  • Stereostatic Body Radiation Therapy
  • (no location specified)
Mar 3, 2023

Prostate Cancer Screening Trial in Chicago (Prostate MRI)

Recruiting
  • Prostate Cancer Screening
  • Prostate MRI
  • Chicago, Illinois
    University of Chicago
Nov 2, 2022

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for

Active, not recruiting
  • Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
  • Docetaxel injection
  • +2 more
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 24, 2022

Men at High Genetic Risk for Prostate Cancer

Recruiting
  • Prostatic Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

    Not yet recruiting
    • High-Risk Prostate Cancer
    • Portland, Oregon
      VA Portland Health Care System, Portland, OR
    Jan 17, 2023

    Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial (External Beam Radiation Therapy, Stereotactic Body

    Not yet recruiting
    • Stage III Prostate Cancer AJCC v8
    • Stage IVA Prostate Cancer AJCC v8
    • External Beam Radiation Therapy
    • Stereotactic Body Radiation Therapy
    • (no location specified)
    Jul 20, 2023

    Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,

    Enrolling by invitation
    • Prostate Neoplasms
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • High Risk
    • Houston, Texas
      Houston Methodist
    Dec 8, 2022

    Prostate Cancer Trial in Bala-Cynwyd (rhPSMA-7.3 (18F))

    Not yet recruiting
    • Prostate Cancer
    • rhPSMA-7.3 (18F)
    • Bala-Cynwyd, Pennsylvania
      MidLantic Urology
    Mar 22, 2023

    Prostate Cancer Trial in Baltimore (Enoblituzumab, Standard of Care)

    Not yet recruiting
    • Prostate Cancer
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Aug 25, 2023

    Prostate Cancer Trial ([18F]-PSMA-1007)

    Not yet recruiting
    • Prostate Cancer
    • [18F]-PSMA-1007
    • (no location specified)
    Jan 30, 2023

    Diagnostic Strategy of High-risk Prostate Cancer

    Not yet recruiting
    • High-risk Prostate Cancer
    • urine collection
    • canine detection
    • Paris, France
      Hopital Bichat - Claude-Bernard
    Sep 26, 2022

    Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

    Not yet recruiting
    • Prostate Cancer
    • Prostate Adenocarcinoma
    • (no location specified)
    Feb 2, 2023

    Prostate Cancer, Prostatic Tumors Trial (64Cu-SAR-bisPSMA)

    Not yet recruiting
    • Prostate Cancer
    • Prostatic Neoplasms
    • (no location specified)
    Sep 21, 2023

    Prostate Cancer, Prostate Disease Trial in Lake Success, New York (Cryo-ablation Using DynaCAD / UroNAV preplanning / guidance)

    Recruiting
    • Prostate Cancer
    • Prostate Disease
    • Cryo-ablation Using DynaCAD / UroNAV preplanning / guidance
    • Lake Success, New York
    • +2 more
    Jan 22, 2022